Format
Sort by

Send to

Choose Destination

Search results

Items: 5

1.

Comparison of enzyme-linked immunosorbent assay systems using rift valley fever virus nucleocapsid protein and inactivated virus as antigens.

Yu F, Adungo F, Konongoi SL, Inoue S, Sang R, Ashur S, Kwallah AO, Uchida L, Buerano CC, Mwau M, Zha Y, Nie Y, Morita K.

Virol J. 2018 Nov 22;15(1):178. doi: 10.1186/s12985-018-1071-y.

2.

Development and Characterization of Monoclonal Antibodies to Yellow Fever Virus and Application in Antigen Detection and IgM Capture Enzyme-Linked Immunosorbent Assay.

Adungo F, Yu F, Kamau D, Inoue S, Hayasaka D, Posadas-Herrera G, Sang R, Mwau M, Morita K.

Clin Vaccine Immunol. 2016 Aug 5;23(8):689-97. doi: 10.1128/CVI.00209-16. Print 2016 Aug.

3.

Application of recombinant severe fever with thrombocytopenia syndrome virus nucleocapsid protein for the detection of SFTSV-specific human IgG and IgM antibodies by indirect ELISA.

Yu F, Du Y, Huang X, Ma H, Xu B, Adungo F, Hayasaka D, Buerano CC, Morita K.

Virol J. 2015 Aug 4;12:117. doi: 10.1186/s12985-015-0350-0.

4.

Evaluation of PIMA™® point of care technology for CD4 T cell enumeration in Kenya.

Mwau M, Adungo F, Kadima S, Njagi E, Kirwaye C, Abubakr NS, Okubi LA, Waihenya M, Lusike J, Hungu J.

PLoS One. 2013 Jun 25;8(6):e67612. doi: 10.1371/journal.pone.0067612. Print 2013.

5.

Influenza: the next pandemic?: A review.

Adungo FO, Adungo NI, Bedno S, Yingst SL.

East Afr Med J. 2005 Sep;82(9):477-81. Review.

PMID:
16619723

Supplemental Content

Loading ...
Support Center